Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel investigational therapeutics for panic disorder
Giampaolo Perna, Koen Schruers, Alessandra Alciati, et al.
Expert Opinion on Investigational Drugs (2014) Vol. 24, Iss. 4, pp. 491-505
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Long-Term Pharmacological Treatments of Anxiety Disorders: An Updated Systematic Review
Giampaolo Perna, Alessandra Alciati, Alice Riva, et al.
Current Psychiatry Reports (2016) Vol. 18, Iss. 3
Closed Access | Times Cited: 64
A pontomesencephalic PACAPergic pathway underlying panic-like behavioral and somatic symptoms in mice
SukJae Joshua Kang, Jong–Hyun Kim, Dong‐Il Kim, et al.
Nature Neuroscience (2024) Vol. 27, Iss. 1, pp. 90-101
Open Access | Times Cited: 6
Treatment-resistant panic disorder: clinical significance, concept and management
Mu‐Hong Chen, Shih‐Jen Tsai
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2016) Vol. 70, pp. 219-226
Closed Access | Times Cited: 56
The Role of Psychotropic Medications in the Management of Anorexia Nervosa: Rationale, Evidence and Future Prospects
Guido Frank, Megan E. Shott
CNS Drugs (2016) Vol. 30, Iss. 5, pp. 419-442
Open Access | Times Cited: 51
Biological and cognitive theories explaining panic disorder: A narrative review
Peter Kyriakoulis, Michael Kyrios
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 10
Management of Treatment-Resistant Panic Disorder
Giampaolo Perna, Daniela Caldirola
Current Treatment Options in Psychiatry (2017) Vol. 4, Iss. 4, pp. 371-386
Open Access | Times Cited: 30
Multiple-dose clinical pharmacology of the selective orexin-1 receptor antagonist ACT-539313
Priska Kaufmann, Marion Anliker‐Ort, Georg Golor, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 108, pp. 110166-110166
Closed Access | Times Cited: 24
Pharmacological and Neuromodulatory Treatments for Panic Disorder: Clinical Trials from 2010 to 2018
Morena Mourao Zugliani, Mariana Costa do Cabo, Antônio Egídio Nardi, et al.
Psychiatry Investigation (2019) Vol. 16, Iss. 1, pp. 50-58
Open Access | Times Cited: 23
First‐in‐human study with ACT‐539313, a novel selective orexin‐1 receptor antagonist
Priska Kaufmann, Marion Anliker‐Ort, Georg Golor, et al.
British Journal of Clinical Pharmacology (2020) Vol. 86, Iss. 7, pp. 1377-1386
Open Access | Times Cited: 23
Pharmacological Therapy in Panic Disorder: Current Guidelines and Novel Drugs Discovery for Treatment-resistant Patient
Isa Naina-Mohamed, Syed-Badrul Syarifah-Noratiqah, Ahmad Nazrun Shuid, et al.
Clinical Psychopharmacology and Neuroscience (2019) Vol. 17, Iss. 2, pp. 145-154
Open Access | Times Cited: 21
Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines
Giampaolo Perna, Alessandra Alciati, Raffaele Balletta, et al.
International Journal of Molecular Sciences (2016) Vol. 17, Iss. 4, pp. 551-551
Open Access | Times Cited: 19
Are there advances in pharmacotherapy for panic disorder? A systematic review of the past five years
Daniela Caldirola, Alessandra Alciati, Alice Riva, et al.
Expert Opinion on Pharmacotherapy (2018) Vol. 19, Iss. 12, pp. 1357-1368
Closed Access | Times Cited: 17
Panic Disorder as Unthinkable Emotions: Alexithymia in Panic Disorder, a Croatian Cross-Sectional Study
Daniela Šago, Goran Babić, Žarko Bajić, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 15
Relapse prevention in panic disorder with pharmacotherapy: where are we now?
Daniela Caldirola, Alessandra Alciati, Silvia Daccò, et al.
Expert Opinion on Pharmacotherapy (2020) Vol. 21, Iss. 14, pp. 1699-1711
Closed Access | Times Cited: 15
FGIN-1-27, an agonist at translocator protein 18 kDa (TSPO), produces anti-anxiety and anti-panic effects in non-mammalian models
Mônica Gomes Lima, Jonathan Cueto‐Escobedo, Juan Francisco Rodríguez‐Landa, et al.
Pharmacology Biochemistry and Behavior (2018) Vol. 171, pp. 66-73
Open Access | Times Cited: 15
Associations of plasma leptin to clinical manifestations in reproductive aged female patients with panic disorder
Vasilios G. Masdrakis, Charalabos Papageorgiou, Manolis Markianos
Psychiatry Research (2017) Vol. 255, pp. 161-166
Closed Access | Times Cited: 13
Personalized Clinical Approaches to Anxiety Disorders
Giampaolo Perna, Alessandra Alciati, Erika Sangiorgio, et al.
Advances in experimental medicine and biology (2020), pp. 489-521
Closed Access | Times Cited: 12
Experimental Drugs for Panic Disorder: An Updated Systematic Review
Daniela Caldirola, Alessandra Alciati, Francesco Cuniberti, et al.
Journal of Experimental Pharmacology (2021) Vol. Volume 13, pp. 441-459
Open Access | Times Cited: 10
A Novel Bio-Psychosocial-Behavioral Treatment Model of Panic Disorder
Seon‐Cheol Park, Yong‐Ku Kim
Psychiatry Investigation (2018) Vol. 16, Iss. 1, pp. 4-15
Open Access | Times Cited: 11
Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack
Luara A. Batista, Andréa Siqueira Haibara, Luiz Carlos Schenberg, et al.
Behavioural Brain Research (2016) Vol. 317, pp. 508-514
Closed Access | Times Cited: 9
Is there a role for pharmacogenetics in the treatment of panic disorder?
Daniela Caldirola, Giampaolo Perna
Pharmacogenomics (2015) Vol. 16, Iss. 8, pp. 771-774
Closed Access | Times Cited: 8
Personalized medicine in panic disorder: where are we now? A meta-regression analysis
Daniela Caldirola, Massimiliano Grassi, Alessandra Alciati, et al.
Personalized Medicine in Psychiatry (2016) Vol. 1-2, pp. 26-38
Open Access | Times Cited: 8
Treatment-Resistant Panic Disorder
Mu‐Hong Chen, Shih‐Jen Tsai
Springer eBooks (2018), pp. 189-206
Closed Access | Times Cited: 4
In vivo investigation on bio-markers of perimenopausal panic disorder and catgut embedding acupoints mechanism
Guizhen Chen, Xue Wang, Shuo Zhang, et al.
Medicine (2020) Vol. 99, Iss. 19, pp. e19909-e19909
Open Access | Times Cited: 4
The Co-Morbidity between Bipolar and Panic Disorder in Fibromyalgia Syndrome
Alessandra Alciati, Fabiola Atzeni, Daniela Caldirola, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3619-3619
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top